-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CQ/SoVl41va362Qd4VqJ0sNIFbBKA+rIK5MYrNRoX1CLMrulSVkzHpjrrt2KZaMs 0y0OM7nlVQA/Y24n2ziU+g== 0001181151-05-000001.txt : 20050506 0001181151-05-000001.hdr.sgml : 20050506 20050506114637 ACCESSION NUMBER: 0001181151-05-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050505 FILED AS OF DATE: 20050506 DATE AS OF CHANGE: 20050506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BADDOUR LINDA CENTRAL INDEX KEY: 0001181151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 05806142 BUSINESS ADDRESS: STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC STREET 2: 3151 S 17TH ST CITY: WILMINGTON STATE: DE ZIP: 28412 BUSINESS PHONE: 9102510081 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-05-05 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181151 BADDOUR LINDA 5208 MASONBORO HARBOR DRIVE WILMINGTON NC 28409 0 1 0 0 Chief Financial Officer Common Stock 2005-05-05 4 M 0 10000 17.00 A 12590 D Common Stock 2005-05-05 4 M 0 7500 21.97 A 20090 D Common Stock 2005-05-05 4 S 0 17500 47.51 D 2590 D Stock options (to purchase) 17.00 2005-05-05 4 M 0 10000 0 D 2002-03-02 2009-03-01 Common Stock 10000 177000 D Stock options (to purchase) 21.97 2005-05-05 4 M 0 7500 0 D 2003-03-12 2011-03-11 Common Stock 7500 169500 D This is the average price of the 17,500 shares sold on 5/5/05. 3,333 options vested on 3/2/00; 3,333 options vested on 3/2/01 and 3,334 vested on 3/2/02. All options were vested on the date reported. 5,000 options vested on 3/12/02; 2,500 options vested on 3/12/03. All options were vested on the date reported. Lisa C. Noecker attorney-in-fact for Linda Baddour 2005-05-06 -----END PRIVACY-ENHANCED MESSAGE-----